# A Smoking Intervention Study Using Scheduled Gradual Reduction With Varenicline to Help With Cessation

> **NCT01772641** · PHASE4 · TERMINATED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 32 (actual)

## Conditions studied

- Nicotine Addiction

## Interventions

- **OTHER:** Scheduled Gradual Reduction + Varenicline
- **OTHER:** Scheduled Gradual Reduction + Placebo Drug
- **OTHER:** Basic Advice + Varenicline
- **OTHER:** Basic Advice + Placebo Drug

## Key facts

- **NCT ID:** NCT01772641
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-12
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 32 (ACTUAL)
- **Why stopped:** difficulty recruiting and retaining participants
- **Last updated:** 2016-03-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01772641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01772641, "A Smoking Intervention Study Using Scheduled Gradual Reduction With Varenicline to Help With Cessation". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01772641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*